Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 2179-2187

  Kar, S ^a   Issa, A M ^b   Seto, D ^a,b   Auld, D S ^a,b   Collier, B ^b   Quirion, R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylcholine; Alzheimer's disease; Choline transport; Transmitter release; Amyloid

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; CHOLINE;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; CHOLINE UPTAKE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME; TISSUE DISTRIBUTION;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0031969880     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70052179.x     Document Type: Article

References (58)

1. Abe E., Casamenti F., Giovannelli L., Scali C., and Pepeu G. (1994) Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636, 162-164.
2. Auld D. S., Kar S., and Quirion R. (1998) β-Amyloid peptides as direct cholinergic neuromodulators: a missing link. Trends Neurosci. 21, 43-49.
3. Bartus R. T., Dean R. L. III, Beer B., and Lipa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
4. Beeson J. G., Shelton E. R., Chan H. W., and Gage F. H. (1994) Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied using five different antibodies. J. Comp. Neurol. 342, 78-96.
5. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
6. Collier B. (1988) The synthesis and storage of acetylcholine in mammalian cholinergic nerve terminals, in Neurotransmitters and Cortical Function: From Molecules to Mind (Avoli M., Reader T. A., Dykes R. W., and Gloor P., eds), pp. 261-276. Plenum Press, New York.
7. Cordell B. (1994) β-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 34, 69-89.
8. Cotman C. W. and Pike C. J. (1994) β-Amyloid and its contributions to neurodegeneration in Alzheimer's disease, in Alzheimer Disease (Terry R. D., Katzman R., and Bick K. L., eds), pp. 305-315. Raven Press, New York.
9. Cummings B. J. and Cotman C. W. (1995) Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346, 1524-1528.
10. DeKosky S. T. and Scheff S. W. (1990) Synapse loss of frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464.
11. Fonnum F. (1969) Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115, 465-472.
12. Galdzicki Z., Fukuyama R., Wadhwani K. C., Rapoport S. I., and Ehrenstein G. (1994) β-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646, 332-336.
13. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
14. Geula C. and Mesulam M. M. (1994) Cholinergic system and related neuropathological predilection patterns in Alzheimer's disease, in Alzheimer Disease (Terry R. D., Katzman R., and Bick K. L., eds), pp. 263-291. Raven Press, New York.
15. Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. (1995) Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into rat nucleus basalis. Neuroscience 66, 781-792.
16. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
17. Goldberg A. M. and McCaman R. E. (1973) The determination of picomole amounts of acetylcholine in mammalian brain. J. Neurochem. 20, 1-8.
18. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
19. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
20. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388.
21. Harkany T., De Jong G. I., Soos K., Penke B., Luiten P. G. M., and Gulya K. (1995a) β-Amyloid 1-42 affects cholinergic but not parvalbumin-containing neurones in the septal complex of the rat. Brain Res. 698, 270-274.
22. Harkany T., Lengyel Z., Soos K., Penke B., Luiten P. G. M., and Gulya K. (1995b) Cholinotoxic effects of β-amyloidl-42 peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res. 695, 71-75.
23. Hohmann C., Antuono P., and Coyle J. T. (1988) Basal forebrain cholinergic neurones and Alzheimer's disease, in Handbook of Psychopharmacology: Psychopharmacology of the Aging Nervous System (Iversen L. L. and Snyder S. H., eds), pp. 69-106. Plenum Press, New York.
24. 1-42 suppresses acetylcholine synthesis. J. Biol. Chem. 272, 2038-2041.
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
26. Issa A. M., Gauthier S., and Collier B. (1996) Effects of the phosphatase inhibitors calyculin A and okadaic acid on acetylcholine synthesis and content of rat hippocampal formation. J. Neurochem. 66, 1924-1932.
27. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., and Nabeshima T. (1996) Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66, 1113-1117.
28. Iverfeldt K., Walaas S. I., and Greengard P. (1993) Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 4146-4150.
29. Kang J., Lemaire G. H., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325, 733-736.
30. Kar S., Seto D., Gaudreau P., and Quirion R. (1996) β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal formation. J. Neurosci. 16, 1034-1040.
31. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S., and Mattson M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
32. Kilbinger H. (1996) Modulation of acetylcholine release by nitric oxide. Prog. Brain Res. 109, 219-224.
33. LeBlanc A. C., Xue R., and Gambetti P. (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 2300-2310.
34. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
35. Maggio J. E., Stimson E. R., Ghilardi J. R., Allen C. J., Dahl C. E., Whitcomb D. C., Vigna S. R., Vinters H. V., Labenski M. E., and Mantyh P. W. (1992) Reversible in vitro growth of Alzheimer's disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89, 5462-5466.
36. Maurice T., Lockhart B. P., and Privat A. (1996) Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res. 706, 181-193.
37. Mullan M. and Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16, 398-402.
38. Murad F. (1994) Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv. Pharmacol. 26, 19-33.
39. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S. A., Massicotte G., Julien J.-P., and Shapiro M. L. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505.
40. Nitsch R. M. and Growdon H. (1994) Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47, 1275-1284.
41. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
42. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. (1994) β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.
43. Ouimet C. C., Baerwald K. D., Gandy S. E., and Greengard P. (1994) Immunocytochemical localization of amyloid precursor protein in the rat brain. J. Comp. Neurol. 348, 244-260.
44. Pedersen W. A., Kloczewiak M. A., and Blusztajn J. K. (1996) Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurones of the basal forebrain. Proc. Natl. Acad. Sci. USA 93, 8068-8071.
45. Prast H. and Philippu A. (1992) Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol. 216, 139-140.
46. Price D. (1986) New perspectives on Alzheimer's disease. Annu. Rev. Neurosci. 9, 489-512.
47. Quirion R. (1993) Cholinergic markers in Alzheimer's disease and the autoregulation of acetylcholine release. J. Psychiatry Neurosci. 18, 226-234.
48. Rylett R. J., Ball M. J., and Colhuon E. H. (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res. 289, 169-175.
49. Satoh S., Murayama T., and Nomura Y. (1996) Sodium nitroprusside stimulates noradrenaline release from rat hippocampal slices in the presence of dithiothreitol. Brain Res. 733, 167-174.
50. Selkoe D. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
51. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer β-peptide from biological fluids. Nature 359, 325-327.
52. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., Makay D. M., Tintner R., Frangione B., and Younkin S. G. (1992) Production of Alzheimer's β protein by normal proteolytic processing. Science 258, 126-129.
53. Tuček S. (1985) Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44, 11-24.
54. Wallace W., Ahlers S. T., Gotlib J., Bragin V., Sugar J., Gluck R., Shea P. A., Davis K. L., and Haroutunian V. (1993) Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. Natl. Acad. Sci. USA 90, 8712-8716.
55. Wecker L. (1991) The synthesis and release of acetylcholine by depolarized hippocampal slices is increased by increased choline available in vitro prior to stimulation. J. Neurochem. 57, 1119-1127.
56. Wurtman R. (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurones. Trends Neurosci. 15, 117-122.
57. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
58. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.